The effect of bariatric surgery in comparison with the control group on the prevention of comorbidities in people with severe obesity: a prospective cohort study

[1]  M. Sohrabi,et al.  Disparities in Obesity Prevalence in Iranian Adults: Cross-Sectional Study Using Data from the 2016 STEPS Survey , 2021, Obesity Facts.

[2]  F. Greenway,et al.  Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. , 2021, JAMA.

[3]  T. Wadden,et al.  Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial , 2021, The Lancet.

[4]  T. Wadden,et al.  Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. , 2021, JAMA.

[5]  T. Wadden,et al.  Once-Weekly Semaglutide in Adults with Overweight or Obesity. , 2021, The New England journal of medicine.

[6]  R. Welbourn,et al.  Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis , 2020, PLoS medicine.

[7]  F. Azizi,et al.  Trends in the Prevalence of Severe Obesity among Tehranian Adults: Tehran Lipid and Glucose Study, 1999-2017. , 2020, Archives of Iranian medicine.

[8]  A. Tahrani,et al.  Impact of bariatric surgery on cardiovascular outcomes and mortality: a population‐based cohort study , 2020, The British journal of surgery.

[9]  A. Gangemi,et al.  Physiologic Mechanisms of Type II Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis and Clinical Implications , 2020, Journal of Gastrointestinal Surgery.

[10]  F. Azizi,et al.  Metabolic health in the Middle East and north Africa. , 2019, The lancet. Diabetes & endocrinology.

[11]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[12]  A. Iannelli,et al.  Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese inpatients: a national French survey between 2008 and 2016 on 328,509 morbidly obese patients. , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[13]  F. Folli,et al.  A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity , 2018, Cardiovascular Diabetology.

[14]  V. Pilone,et al.  Bariatric Surgery Versus Lifestyle Intervention in Class I Obesity: 7–10-Year Results of a Retrospective Study , 2018, World Journal of Surgery.

[15]  J. Himpens,et al.  Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018 , 2018, Obesity Surgery.

[16]  S. Msika,et al.  Multicentre cohort study of antihypertensive and lipid‐lowering therapy cessation after bariatric surgery , 2018, The British journal of surgery.

[17]  S. Skinner,et al.  Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding , 2018, Obesity Surgery.

[18]  S. Msika,et al.  Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later , 2018, JAMA surgery.

[19]  J. Hjelmesæth,et al.  Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities , 2018, JAMA.

[20]  P. Greenland,et al.  Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality , 2018, JAMA.

[21]  Hynek Pikhart,et al.  Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants , 2017, The Lancet.

[22]  M. M. Rahman,et al.  Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .

[23]  Ross Arena,et al.  Obesity and Prevalence of Cardiovascular Diseases and Prognosis-The Obesity Paradox Updated. , 2016, Progress in cardiovascular diseases.

[24]  G. Pacini,et al.  Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study , 2016, Hormone and Metabolic Research.

[25]  F. Azizi,et al.  Bariatric Surgery for Morbid Obesity: Tehran Obesity Treatment Study (TOTS) Rationale and Study Design , 2016, JMIR research protocols.

[26]  F. Tinahones,et al.  Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[27]  P. Iozzo,et al.  The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. , 2015, The Journal of clinical endocrinology and metabolism.

[28]  C. Apovian,et al.  Guidelines (2013) for managing overweight and obesity in adults , 2014 .

[29]  Donna Ryan,et al.  Preface to the full report , 2014, Obesity.

[30]  T. Lehtimäki,et al.  Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. , 2014, Journal of hepatology.

[31]  Deepak L. Bhatt,et al.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials , 2013, BMJ.

[32]  S. Adams,et al.  Obesity-related hypertension and its remission following gastric bypass surgery – A review of the mechanisms and predictive factors , 2013, Blood pressure.

[33]  L. Sjöström.  Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery , 2013, Journal of internal medicine.

[34]  C. Bouchard,et al.  Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. , 2012, The New England journal of medicine.

[35]  B. Geloneze,et al.  Early Improvement in Glycemic Control After Bariatric Surgery and Its Relationships with Insulin, GLP-1, and Glucagon Secretion in Type 2 Diabetic Patients , 2011, Obesity surgery.

[36]  T. Śledziński,et al.  Increased Serum Nitric Oxide Concentration After Bariatric Surgery—A Potential Mechanism for Cardiovascular Benefit , 2010, Obesity surgery.

[37]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.

[38]  Farzad Hadaegh,et al.  Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II , 2009, Trials.

[39]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[40]  J. Lekakis,et al.  Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study , 2007, Journal of hypertension.

[41]  C. Apovian,et al.  Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. , 2005, The American journal of cardiology.

[42]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[43]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[44]  P. Blackman.  Actual causes of death in the United States. , 1994, JAMA.

[45]  G. O. Lignac.  [Actual causes of death]. , 1951, Nederlands tijdschrift voor geneeskunde.

[46]  F. Greenway,et al.  Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial , 2021 .

[47]  K. Smith,et al.  Obesity Statistics. , 2016, Primary care.

[48]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..